| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $238.1M | +42.3% |
| Cost of Revenue | $70.4M | +36.1% |
| Gross Profit | $167.6M | +45.1% |
| R&D Expense | $80.6M | +67.0% |
| SG&A Expense | $53.6M | -3.1% |
| Pre-tax Income | -$92.6M | -25.2% |
| Income Tax | $796K | -22.6% |
| Net Income | -$93.4M | -24.5% |
| EPS (Basic) | -$0.84 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $218.5M | -28.9% |
| Short-term Investments | $12.0M | — |
| Accounts Receivable | $22.7M | +11.1% |
| Current Assets | $284.4M | -19.9% |
| Total Assets | $413.8M | +3.3% |
| Current Liabilities | $109.2M | +20.5% |
| Total Liabilities | $118.8M | +26.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.4M | +83.0% |
| Capital Expenditures | $3.6M | +137.5% |
| Investing Cash Flow | -$89.4M | -5867.5% |
| Financing Cash Flow | $5.8M | -97.4% |
| Free Cash Flow | -$9.0M | +72.9% |
| +42.5% |
| EPS (Diluted) | -$0.84 | +42.5% |
| Stockholders' Equity |
| $295.0M |
| -3.8% |